Abstract
Daclizumab is a humanized monoclonal antibody directed towards CD25, the alpha subunit of the high-affinity interleukin (IL)-2 receptor. Daclizumab ex......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
